Trade Mark Journal No.2026/045 6 November 2026

UK00004462588 20 October 2026 (5)

RYSEZRA

International priority date claimed: 28 April 2026 (United States of America) (99791630)

Class 5: Pharmaceutical preparations for the treatment of autoimmune, inflammatory, and immune-mediated diseases and disorders; Pharmaceutical preparations for the treatment of diseases and conditions of the immune system; Pharmaceutical preparations for the treatment of Sjögren’s syndrome and related conditions; Pharmaceutical preparations for the treatment of dryness of the eyes and mouth; Pharmaceutical preparations.

Viela Bio, Inc.

Representative: Stevens Hewlett & Perkins